Stock Under $10 with 50-100% upside potential - 14 Days FREE!

TSC Ratings Update: 'Hold' Healthways

Stock quotes in this article: HWAY 

Healthways' cash and cash equivalents plunged 92.0% to $4.35 million from $54.53 million. Net operating cash flow declined 15.0% to $21.65 million when compared to the same quarter last year. Return on assets increased 123 basis points to 6.37% from 5.14%. Similarly, return on equity advanced 377 basis points to 15.33% from 11.56% a year ago. Total debt for the quarter spiked 6.4% to $307.10 million from $288.72 million. Stockholders' equity declined 4.7% to $366.75 million from $384.66 million. Therefore, the debt-to-equity ratio deteriorated to 0.84 from 0.75. Moreover, the company has a quick ratio of 0.75 which shows its inability to meet short-term cash requirements.

During the quarter under review, Healthways signed a new agreement wit a Fortune 100 company to provide comprehensive Health and Care Support solution for more than 90,000 employees and dependents. Also, the company launched new senior solution for the Medicare Advantage population of a large Blue Cross Blue Shield Plan. The company also announced the appointment of Mr. Brueckner to serve as President and Chief Operating Officer.

Recently, the company signed a five-year agreement with the Hospitals Contribution Fund of Australia Limited (HCF) to offer comprehensive Health and Care Support solution.

Looking forward to FY09, the company expects run rate revenue to decline by approximately $90.00 million to $100.00 million over FY08 which would in turn lead to an increase in cost of services and/or selling, general and administrative expenses as a percentage of revenue. In addition, the company also anticipates higher legal expenses.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,307.17 -80.41 -0.52%
NASDAQ 3,463.30 -38.82 -1.11%
S&P 500 1,655.35 -13.81 -0.83%
US 10 Yr 2.026% +0.082

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs